CA
EXEL icon

Centerpoint Advisors’s Exelixis EXEL Stock Holding History

Centerpoint Advisors’s Portfolio EXEL Stock Details EXEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-750
Closed -$28K – 404
2025
Q1 		$28K Hold
750
– – 0.01% 200
2024
Q4 		$25K Hold
750
– – 0.01% 228
2024
Q3 		$19K Buy
+750
New +$18.6K 0.01% 282

Other funds holding EXEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Centerpoint Advisors's EXEL Position: Q2 2025 in Review

Centerpoint Advisors sold out of Exelixis (EXEL) in Q2 2025, closing a stake of 750 shares — an estimated $28K sold.

Centerpoint Advisors first reported a position in EXEL in Q3 2024 and held it in 3 quarters. The position peaked at $28K in Q1 2025. 633 funds tracked by Wall St. Rank hold EXEL as of Q2 2025.

  • Centerpoint Advisors reported no remaining Exelixis position as of Q2 2025 after selling out during the quarter.
  • Centerpoint Advisors sold 750 Exelixis shares in Q2 2025, an estimated $28K.
  • Centerpoint Advisors first reported a position in Exelixis in Q3 2024 and held it in 3 quarters.
  • Centerpoint Advisors's Exelixis position peaked at $28K in Q1 2025.
  • 633 funds tracked by Wall St. Rank held Exelixis as of Q2 2025.

Based on Centerpoint Advisors's 13F filing for Q2 2025, filed 1 Aug 2025.